KALA BIO, INC. Increase (Decrease) in Other Noncurrent Liabilities
KALA BIO, INC. (KALA) reported Increase (Decrease) in Other Noncurrent Liabilities of -$8.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2018-11-08
- KALA BIO, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2018-09-30 was $0.00.
- KALA BIO, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2017-12-31 was -$5.00K, a 266.67% decline year-over-year.
- KALA BIO, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2017-09-30 was -$6.00K.
- KALA BIO, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2017-06-30 was -$14.00K.
- KALA BIO, INC. increase (decrease) in other noncurrent liabilities for fiscal 2017 was -$7.00K.
- KALA BIO, INC. increase (decrease) in other noncurrent liabilities for fiscal 2016 was -$19.00K.
- KALA BIO, INC. increase (decrease) in other noncurrent liabilities for fiscal 2015 was -$36.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$8.00K 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | -$8.00K 10-Q · filed 2018-08-09 | |||
| 2017-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$11.00K derived: sum of 2 quarters · filed 2018-11-08 | -$25.00K derived: sum of 3 quarters · filed 2018-11-08 | -$7.00K 10-K · filed 2018-04-02 |
| 2017-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$20.00K derived: sum of 2 quarters · filed 2018-11-08 | -$2.00K 10-Q · filed 2018-11-08 | $1.00K derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $4.00K 10-Q · filed 2018-08-09 | $7.00K derived: sum of 3 quarters · filed 2018-08-09 | $3.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $18.00K 10-Q · filed 2018-05-10 | $21.00K derived: sum of 2 quarters · filed 2018-05-10 | $17.00K derived: sum of 3 quarters · filed 2018-05-10 | |
| 2016-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$1.00K derived: sum of 2 quarters · filed 2018-04-02 | -$19.00K 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$22.00K 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | -$18.00K 10-Q · filed 2017-08-31 | |||
| 2015-12-31 | -$36.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |